التفاصيل البيبلوغرافية
| العنوان: |
A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening. |
| المؤلفون: |
Fan, Xiao‐Han, Zhang, Yang, Wang, Pei, Song, Qian‐Qian, Wang, Mona, Mejias‐Luque, Raquel, Li, Zhe‐Xuan, Zhou, Tong, Zhang, Jing‐Ying, Liu, Wei‐Dong, Zhang, Lan‐Fu, Li, Wen‐Qing, You, Wei‐Cheng, Gerhard, Markus, Jiao, Yu‐Chen, Wang, Xiao‐Bing, Pan, Kai‐Feng |
| المصدر: |
International Journal of Cancer; Mar2024, Vol. 154 Issue 6, p1111-1123, 13p |
| مصطلحات موضوعية: |
STOMACH cancer, EARLY detection of cancer, RISK assessment, PRECANCEROUS conditions, PROMOTERS (Genetics), HELICOBACTER pylori infections |
| مستخلص: |
Effective screening and early detection are critical to improve the prognosis of gastric cancer (GC). Our study aims to explore noninvasive multianalytical biomarkers and construct integrative models for preliminary risk assessment and GC detection. Whole genomewide methylation marker discovery was conducted with CpG tandems target amplification (CTTA) in cfDNA from large asymptomatic screening participants in a high‐risk area of GC. The methylation and mutation candidates were validated simultaneously using one plasma from patients at various gastric lesion stages by multiplex profiling with Mutation Capsule Plus (MCP). Helicobacter pylori specific antibodies were detected with a recomLine assay. Integrated models were constructed and validated by the combination of multianalytical biomarkers. A total of 146 and 120 novel methylation markers were found in CpG islands and promoter regions across the genome with CTTA. The methylation markers together with the candidate mutations were validated with MCP and used to establish a 133‐methylation‐marker panel for risk assessment of suspicious precancerous lesions and GC cases and a 49‐methylation‐marker panel as well as a 144‐amplicon‐mutation panel for GC detection. An integrated model comprising both methylation and specific antibody panels performed better for risk assessment than a traditional model (AUC, 0.83 and 0.63, P <.001). A second model for GC detection integrating methylation and mutation panels also outperformed the traditional model (AUC, 0.82 and 0.68, P =.005). Our study established methylation, mutation and H. pylori‐specific antibody panels and constructed two integrated models for risk assessment and GC screening. Our findings provide new insights for a more precise GC screening strategy in the future. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Cancer is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder